Amyloid Imaging PET Ligands as Biomarkers for Alzheimer’s Disease, Preclinical Evaluation

QR-Code

Amyloid Imaging PET Ligands as Biomarkers for Alzheimer’s Disease, Preclinical Evaluation

None

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Svedberg, Marie, Hellström-Lindahl, Ewa, Rahman, Obaidur, Hall, Håkan
Format:	Elektronisch Buchkapitel
Sprache:	Englisch
Veröffentlicht:	IntechOpen 2012
Schlagworte:	Health Sciences
Online-Zugang:	https://www.intechopen.com/chapters/27818
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Diagnostic Challenge in Frontal Variant Alzheimer's Disease With Low Amyloid‐β PET Retention
von: Ryosuke Shimasaki, et al.
Veröffentlicht: (2025-07-01)

Understanding the impact of amyloid beta targeted therapies on biomarkers and clinical endpoints in Alzheimer's disease
von: Ronald C. Petersen, et al.
Veröffentlicht: (2025-04-01)

Image quality evaluation for two different positron emitters in a preclinical PET scanner
von: Rodrigo Modesto Gadelha, et al.
Veröffentlicht: (2020-09-01)

The Clinical Use of SPECT and PET Molecular Imaging in Alzheimer’s Disease
von: Valotassiou, Varvara, et al.
Veröffentlicht: (2011)

Spatial resolution of a preclinical PET tomograph
von: Guilherme Cavalcante de Albuquerque Souza, et al.
Veröffentlicht: (2021-04-01)

Task-Related EEG as a Biomarker for Preclinical Alzheimer’s Disease: An Explainable Deep Learning Approach
von: Ziyang Li, et al.
Veröffentlicht: (2025-07-01)

Tau and Amyloid- Conformational Change to  -Sheet Structures as Effectors in the Development of Alzheimer's Disease
von: Anda-Hernández, Martha A. De, et al.
Veröffentlicht: (2012)

Anti-amyloid Monoclonal Antibodies for Alzheimer’s Disease: A New Hope? (Review)
von: I. A. Mazerkina
Veröffentlicht: (2025-04-01)

A novel view on Alzheimer’s disease pathogenesis: modern conceptof amyloid clearance
von: V. Yu. Lobzin, et al.
Veröffentlicht: (2018-11-01)

Animal models of Alzheimer’s disease: preclinical insights and challenges
von: Qing-Qing Xu, et al.
Veröffentlicht: (2023-05-01)

Diagnostic value of fluid‐based non‐amyloid biomarkers for Alzheimer's disease and related dementias in a clinic‐based cohort from South Asia
von: Faheem Arshad, et al.
Veröffentlicht: (2025-04-01)

Consistency Analysis of Centiloid Values Across Three Commercial Software Platforms for Amyloid PET Quantification
von: Hyukjin Yoon, et al.
Veröffentlicht: (2025-06-01)

Estimating the optimal cutoff for the IGT‐AD Distress subscale adapted for amyloid PET results disclosure
von: Dianxu Ren, et al.
Veröffentlicht: (2025-04-01)

The Efficacy of Anti-amyloid Monoclonal Antibodies in Early Alzheimer’s Dementia: A Systematic Review
von: Alyaa Mostafa, et al.
Veröffentlicht: (2025-05-01)

Mannose Promotes β‐Amyloid Pathology by Regulating BACE1 Glycosylation in Alzheimer's Disease
von: Chensi Liang, et al.
Veröffentlicht: (2025-03-01)

Role of neuronal fabp in autophagy and amyloid-β pathology in a Drosophila model of Alzheimer disease
von: Byoungyun Choi, et al.
Veröffentlicht: (2025-12-01)

PET Imaging of Gliomas
von: Bansal, Aditya, et al.
Veröffentlicht: (2011)

Amyloid-beta 40 as a biomarker of cognitive impairment in acute ischemic stroke
von: Aleksey A. Kulesh, et al.
Veröffentlicht: (2017-10-01)

Effects of PET image reconstruction parameters and tumor-to-background uptake ratio on quantification of PET images from PET/MRI and PET/CT systems
von: Amena Ali Hussain, et al.
Veröffentlicht: (2024-09-01)

Systematic search for peptide and protein ligands of human serum albumin capable of affecting its interaction with amyloid β peptide
von: E. V. Loktyushov, et al.
Veröffentlicht: (2022-12-01)

Comparative Safety Profiles of Anti-Amyloid Therapies in Early Alzheimer’s Disease (AD): A Detailed Systematic Review and Meta-Regression Analysis of Amyloid Related Imaging Abnormalities (ARIA) – Incidence and Infusion Reactions for Lecanemab, Donanemab, and Aducanumab
von: Sathyan Soundara Rajan, et al.
Veröffentlicht: (2025-06-01)

Solving the Amyloid Paradox: Unveiling the Complex Pathogenicity of Amyloid Fibrils
von: Maksim I. Sulatsky, et al.
Veröffentlicht: (2025-07-01)

Image quality evaluation of a small animal PET scanner
von: Andréa Vidal Ferreira, et al.
Veröffentlicht: (2020-03-01)

Development and preclinical characterization of AMG 329: a human antibody neutralizing FLT3 ligand
von: Annie Lau-Kilby, et al.
Veröffentlicht: (2025-12-01)

PET Imaging in Gastric Carcinoma
von: Kamimura, Kiyohisa, et al.
Veröffentlicht: (2011)

Free Software for PET Imaging
von: Prieta, Roberto de la
Veröffentlicht: (2012)

Efficacy and safety of passive immunotherapies targeting amyloid beta in Alzheimer's disease: A systematic review and meta-analysis.
von: Reina Tonegawa-Kuji, et al.
Veröffentlicht: (2025-03-01)

Nose-to-brain delivery of targeted lipid nanoparticles as two-pronged β-amyloid nanoscavenger for Alzheimer's disease therapy
von: Yanyan Xu, et al.
Veröffentlicht: (2025-06-01)

Prevalence of cerebral amyloid angiopathy and its correlation with Alzheimer's disease and cognition in an autopsy‐confirmed cohort from China
von: Xiang‐Sha Yin, et al.
Veröffentlicht: (2025-04-01)

Relationship between tau-PET and quantitative susceptibility mapping in atypical Alzheimer’s disease
von: Neha Singh-Reilly, et al.
Veröffentlicht: (2025-07-01)

Alzheimer’s Diseases: Towards Biomarkers for an Early Diagnosis
von: Elmoualij, Benaïssa, et al.
Veröffentlicht: (2011)

Amyloid tumor of the breast
von: Makiko Mori, et al.
Veröffentlicht: (2019-02-01)

Predicting amyloid status in mild cognitive impairment: the role of semantic intrusions combined with plasma biomarkers
von: Yao Lu, et al.
Veröffentlicht: (2025-06-01)

Recent Preclinical Evidence on Phytocannabinoids in Neurodegenerative Disorders: A Focus on Parkinson’s and Alzheimer’s Disease
von: Nicoleta-Mirela Blebea, et al.
Veröffentlicht: (2025-06-01)

Cerebrospinal fluid β-amyloid1-42 levels in the differential diagnosis of Alzheimer's disease--systematic review and meta-analysis.
von: Jin-A Mo, et al.
Veröffentlicht: (2015-01-01)

PET and SPECT Imaging of Tumor Angiogenesis
von: Dort, Marcian E. Van, et al.
Veröffentlicht: (2012)

Oxidative Stress in Alzheimer’s Disease: Pathogenesis, Biomarkers and Therapy
von: Gella, Alejandro, et al.
Veröffentlicht: (2011)

Blood‐based biomarkers of Alzheimer's disease: Standardization and comprehensiveness
von: Ying Liu, et al.
Veröffentlicht: (2024-12-01)

Use of Model‐Based Meta‐Analysis to Inform the Design of Early Clinical Trials of Anti‐Amyloid Beta Therapies in Alzheimer's Disease
von: Sagar S. Bachhav, et al.
Veröffentlicht: (2025-07-01)

Amyloid cardiomyopathy: сlinical significance and diagnostic value of magnetic resonance imaging
von: M. V. Ezhikova, et al.
Veröffentlicht: (2024-11-01)